Management of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020
В. Б. Гриневич, И. В. Губонина, В. Л. Дощицин, Yu. V. Kotovskaya, Yu. A. Kravchuk, V. I. Ped, Е. И. Сас, Andrei V. Syrov, Alexey B. Tarasov, А. И. Тарзиманова, О. Н. Ткачева, Д. И. Трухан
Abstract
The pandemic of the novel coronavirus infection (COVID-19), caused by SARS‑CoV‑2, has become a challenge to healthcare systems in all countries of the world. Patients with comorbidity are the most vulnerable group with the high risk of adverse outcomes. The problem of managing these patients in context of a pandemic requires a comprehensive approach aimed both at the optimal management in self-isolated patients not visiting medical facilities, and management of comorbidities in patients with COVID-19. The presented consensus covers these two aspects of managing patients with cardiovascular disease, diabetes, chronic obstructive pulmonary disease, gastrointestinal disease, and also pay attention to the multiple organ complications of COVID-19.